Phenotypic drug discovery has been highlighted in the past decade as an important strategy in the discovery of new medical
entities. How many marketed drugs are derived from phenotypic screens? From the most recent examples, what were the factors
enabling target identification and validation? This book answers these questions by elaborating on fundamental capabilities
required for phenotypic drug discovery and using case studies to illustrate approaches and key success factors. Written and
edited by experienced practitioners from both industry and academia, this publication will equip researchers with a thought-provoking
guide to the application and future development of contemporary phenotypic drug discovery for clinical success.